BlackBerry (NYSE:BB) and Enfusion (NYSE:ENFN) Head-To-Head Analysis

BlackBerry (NYSE:BB) and Enfusion (NYSE:ENFN) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations for BlackBerry and Enfusion, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BlackBerry	0	6	1	1	2.38
Enfusion	3	2	1	0	1.67

BlackBerry presently has a consensus price target of $3.20, indicating a potential upside of 29.03%. Enfusion has a consensus price target of $9.33, indicating a potential upside of 9.55%. Given BlackBerry’s stronger consensus rating and higher probable upside, research analysts clearly believe BlackBerry is more favorable than Enfusion.

Profitability

This table compares BlackBerry and Enfusion’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BlackBerry	-25.80%	-6.30%	-3.47%
Enfusion	1.40%	6.60%	4.86%

Earnings & Valuation

This table compares BlackBerry and Enfusion’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BlackBerry	$853.00 million	1.72	-$130.00 million	($0.29)	-8.55
Enfusion	$174.54 million	6.25	$6.03 million	$0.03	284.09

Enfusion has lower revenue, but higher earnings than BlackBerry. BlackBerry is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

BlackBerry has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Institutional and Insider Ownership

54.5% of BlackBerry shares are held by institutional investors. Comparatively, 81.1% of Enfusion shares are held by institutional investors. 0.3% of BlackBerry shares are held by company insiders. Comparatively, 36.4% of Enfusion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Enfusion beats BlackBerry on 9 of the 14 factors compared between the two stocks.

About BlackBerry

BlackBerry Limited provides intelligent security software and services to enterprises and governments worldwide. The company operates through three segments: Cybersecurity, IoT, and Licensing and Other. The company offers CylanceENDPOINT, an integrated endpoint security solution; CylanceGUARD, a managed detection and response solution; CylanceEDGE, an AI-powered continuous authentication zero trust network access solution; CylanceINTELLIGENCE, a contextual cyber threat intelligence service; BlackBerry Dynamics offers a development platform and secure container for mobile applications; BlackBerry Workspaces a secure Enterprise File Sync and Share (EFSS) solution; BlackBerry Messenger (BBM) Enterprise, an enterprise-grade secure instant messaging solution for messaging, voice and video; BlackBerry SecuSUITE is a certified, multi-OS voice and text messaging solution; BlackBerry AtHoc, a secure networked critical event management solution; and BlackBerry unified endpoint management (UEM) solutions. It also provides BlackBerry Technology Solutions (BTS); BlackBerry Certicom, a patented elliptic curve cryptography, which provides device security, anti-counterfeiting and product authentication solutions; BlackBerry Radar offers monitoring and telematics solutions; BlackBerry Professional; and cyber security consulting services. In addition, the company is involved in the patent licensing and legacy service access fees business. The company was formerly known as Research In Motion Limited and changed its name to BlackBerry Limited in July 2013. BlackBerry Limited was incorporated in 1984 and is headquartered in Waterloo, Canada.

About Enfusion

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.